A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

The vote by the U.S. Senate Finance Committee paves the way for the full Senate to vote to confirm him as secretary of the ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case that Moderna had breached the U.K. marketing code. Initially, the PMCPA ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Investors have two technology companies that will open higher this morning. Palantir (PLTR) may open at around 15% after the company posted fourth-quarter results late Monday. The software AI supplier ...

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

US mRNA specialist Moderna demonstrated substantial R&D investment and progress in the UK, two years since signing its ...